Staff Writer

Sanofi’s Rilzabrutinib Receives Orphan Designation for IgG4-Related Dis...
PADCEV KEYTRUDA Urothelial Cancer: Advancements in Survival Outcomes and Econ...
France’s HAS Denies Ribociclib Breast Cancer Therapy for Early HR+/HER2...
FDA Approved Eye Drops: Lenz Therapeutics Launches VIZZ for Presbyopia Treatment
AI in Real-World Evidence: Insights from Mitch Higashi
Navigating AI Act Implementation Challenges in MedTech